Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 213724
Company: COSETTE

Products on ANDA 213724

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
HYDROCORTISONE VALERATE	HYDROCORTISONE VALERATE	0.2%	CREAM;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 213724

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/11/2021	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 213724

HYDROCORTISONE VALERATE

CREAM;TOPICAL; 0.2%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
HYDROCORTISONE VALERATE	HYDROCORTISONE VALERATE	0.2%	CREAM;TOPICAL	Prescription	No	AB	213724	COSETTE
HYDROCORTISONE VALERATE	HYDROCORTISONE VALERATE	0.2%	CREAM;TOPICAL	Prescription	No	AB	211047	ENCUBE ETHICALS
HYDROCORTISONE VALERATE	HYDROCORTISONE VALERATE	0.2%	CREAM;TOPICAL	Prescription	No	AB	211129	GLENMARK PHARMS LTD
HYDROCORTISONE VALERATE	HYDROCORTISONE VALERATE	0.2%	CREAM;TOPICAL	Prescription	No	AB	210307	LUPIN LTD
HYDROCORTISONE VALERATE	HYDROCORTISONE VALERATE	0.2%	CREAM;TOPICAL	Prescription	No	AB	075666	PADAGIS ISRAEL
HYDROCORTISONE VALERATE	HYDROCORTISONE VALERATE	0.2%	CREAM;TOPICAL	Prescription	No	AB	075042	TARO